Precigen stock rises 16% as Q3 collaboration/licensing revenue surges

Nov. 10, 2022 12:45 PM ETPrecigen, Inc. (PGEN)By: Ravikash, SA News Editor

Stock Market Capital Gains Increasing From A Bull Market


  • Precigen (NASDAQ:PGEN) stock rose ~16% on Thursday after Q3 results beat estimates.
  • Net income was $87.38M, compared to net loss of -$29.76M in Q3 2021.
  • Total revenues grew +401.71% Y/Y to $16.72M.
  • Collaboration and licensing revenues increased to $14.56M, compared to $22K in

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.